Pseudomyxoma Peritonei — Trials

Pseudomyxoma Peritonei — Trials · CancerIndex

Clinical trials

Registered studies

32 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 10
Recruiting: 6
Ph III recruiting: 1
Growth YoY: —
Industry share: 0%
Top sponsor: Aerospace Center Hospital
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05321329	Adjuvant CAPECITABINE in High Risk PSEUDOMYXOMA PERITONEI Patients(ACAPP)	unknown	Phase 2	28	Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER	1	Apr 11, 2022	clinicaltrials
NCT03976973	BromAc for Recurrent Peritoneal Mucinous Tumour or Pseudomyxoma Peritonei	unknown	Phase 2	62	Mucpharm Pty LtdINDUSTRY	0	Mar 15, 2022	clinicaltrials